Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187-Reference-Cited by-同舟云学术

Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187

Published:2018-05 Issue: Volume:154 Page:321-331
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Dömötör Orsolya,Pelivan Karla,Borics Attila^ORCID,Keppler Bernhard K.,Kowol Christian R.,Enyedy Éva A.

Funder

National Research

Development and Innovation Office FK

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference43 articles.

1. Tyrosine kinase – role and significance in Cancer;Paul;Int. J. Med. Sci.,2004

2. Epidermal growth factor receptor mutations in lung cancer, D.A. Haber;Sharma;Nat. Rev. Cancer,2007

3. Chemistry and Pharmacology of Anticancer Drugs;Thurston,2007

4. Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications;Juan;Ther. Adv. Med. Oncol.,2017

5. Impact of albumin on drug delivery?new applications on the horizon;Elsadek;J. Control. Release,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins;Frontiers in Pharmacology;2024-05-16

2. In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692;European Journal of Pharmaceutical Sciences;2024-01

3. Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation;Journal of Inorganic Biochemistry;2023-01

4. Binding Sites of Anticancer Drugs on Human Serum Albumin (HSA): A Review;Protein & Peptide Letters;2022-08

5. Intrinsically Fluorescent Anti-Cancer Drugs;Biology;2022-07-28